Cargando…
Long-term transgene expression and inhibition of HIV-1 replication by a Cre/loxP-EBNA-1/oriP HIV-1-dependent ribozyme vector: Applications for HIV-1 gene therapy
The cleavage of target mRNA by ribozymes is being exploited as a means of gene silencing in nucleic-acid-based therapies. We previously established an HIV-1-dependent ribozyme-expression vector system, based on Cre-loxP technology with an LTR-gag-p17 promoter as a molecular switch for use in acute H...
Autores principales: | Nagawa, Takashi, Habu, Yuichiro, Matsumoto, Norihiko, Miyano-Kurosaki, Naoko, Takaku, Hiroshi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Library Publishing Media
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737208/ https://www.ncbi.nlm.nih.gov/pubmed/19771216 |
Ejemplares similares
-
Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy
por: Suzuki, Hitoshi, et al.
Publicado: (2009) -
Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells
por: Askautrud, Hanne A, et al.
Publicado: (2009) -
Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 – new vectors for in vitro and in vivo delivery
por: Magin-Lachmann, Christine, et al.
Publicado: (2003) -
HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus
por: Dheekollu, Jayaraju, et al.
Publicado: (2016) -
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
por: Drozd, Anna M., et al.
Publicado: (2015)